FDA NDC
BIXLENVO
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 61958-3601
- Proprietary name
- BIXLENVO
- Nonproprietary name
- bictegravir/lenacapavir
- Labeler
- Gilead Sciences, Inc.
- Dosage form
- TABLET, FILM COATED
- Strength
- 75 mg/1
Run it in Rivvi
Which 2027 plans near you dropped or restricted bictegravir/lenacapavir?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.